Biotech RenovaCare Investors Seek OK Of $2M Deal
By Emilie Ruscoe · September 24, 2024, 10:30 PM EDT
Biotechnology company RenovaCare Inc. has reached a $2 million deal to end a consolidated proposed class action alleging it pumped its stock prices by using a secret paid promotional campaign, the...
To view the full article, register now.